Aurobindo Pharma Limited tumbles 7% on muted Q4

Aurobindo Pharma fell as much as 7.45% on early Tuesday on muted quarterly numbers. The drug firm on Monday reported a marginal decline in its net profit at Rs 528.5 crore for the fourth quarter to March 2018.
Its net profit read Rs 532.5 crore in the previous fiscal. Revenue from operations, however, rose to Rs 4,049.1 crore for January-March, compared with Rs 3,641.6 crore earlier, Aurobindo Pharma said in a regulatory filing.

For Real Time News & Trading Trends Keep Liking Epic Research Private Limited

Facebook

Twitter

YouTube

Pinterest

Linkedin

Google+

Share Button

About the Author

Epic Research
Epic Research
Epic Research - Investment Adviser is a leading financial services provider with presence in Indian and other global capital markets. Call on - 0731-664-2300